VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ORIC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ORICORIC Pharmaceuticals, Inc.
$10.15$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksORICQuarterly Financials

ORIC Pharmaceuticals, Inc. (ORIC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ORIC Pharmaceuticals, Inc. (ORIC) quarterly income statement — complete revenue, gross profit & net income history

ORIC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0320K000304K00261K263K0000000000
COGS % of Revenue--------------------
Gross Profit0-320K000-304K00-261K-263K0000000000
Gross Margin %--------------------
Gross Profit Growth %--5.26%--100%-15.59%--------------
Operating Expenses39.62M34.23M36.67M39.06M32.72M39.27M38.32M36.02M28.73M31.16M28.68M24.99M25.68M22.12M25.69M20.7M23.26M22.8M18.46M21.06M
OpEx % of Revenue--------------------
Selling, General & Admin8.18M8.7M7.9M8.52M8.08M7.3M7.12M7.08M6.77M6.68M6.29M6.21M6.16M5.82M5.97M6.86M6.43M6.06M5.56M5.54M
SG&A % of Revenue--------------------
Research & Development31.44M25.86M28.77M30.55M24.64M31.97M31.2M28.94M21.96M24.48M22.39M18.79M19.52M16.3M14.72M13.83M16.83M16.75M12.9M15.52M
R&D % of Revenue--------------------
Other Operating Expenses0-320K0000000000001000K00000
Operating Income-39.62M-34.55M-36.67M-39.06M-32.72M-39.57M-38.32M-36.02M-28.99M-31.43M-28.68M-24.99M-25.68M-22.12M-25.69M-20.7M-23.26M-22.8M-18.46M-21.06M
Operating Margin %--------------------
Operating Income Growth %-21.09%12.68%4.3%-8.46%-12.86%-25.91%-33.6%-44.11%-12.9%-42.09%-11.63%-20.76%-10.41%3.01%-39.22%1.71%-40.51%19.37%27.91%-89.31%
EBITDA-39.35M-34.23M-36.38M-38.75M-32.42M-39.27M-38.05M-35.74M-28.73M-31.16M-28.43M-24.73M-25.43M-21.87M-25.47M-20.45M-23.01M-22.58M-18.24M-20.84M
EBITDA Margin %--------------------
EBITDA Growth %-21.39%12.82%4.38%-8.42%-12.83%-25.99%-33.85%-44.52%-13%-42.49%-11.59%-20.95%-10.51%3.12%-39.66%1.85%-40.94%19.51%28.09%-91.55%
D&A (Non-Cash Add-back)270K320K288K310K302K304K270K272K261K263K257K259K253K247K221K247K251K229K217K222K
EBIT-39.62M-30.5M-32.59M-39.06M-32.72M-36.31M-38.32M-36.02M-28.99M-28.33M-28.68M-24.99M-25.68M-22.12M-20.69M-20.7M-23.26M-22.8M-18.46M-21.06M
Net Interest Income00000004.05M3.98M1.11M3.2M2.05M1.73M1.27M865K409K99K34K30K33K
Interest Income00000004.05M3.98M3.1M3.2M2.05M1.73M1.27M865K409K99K34K30K33K
Interest Expense0000000001.99M0000000000
Other Income/Expense3.85M4.05M4.08M2.71M2.7M3.26M3.75M4.05M3.98M3.1M3.2M2.05M1.73M1.27M865K409K99K34K30K48K
Pretax Income-35.77M-30.5M-32.59M-36.35M-30.02M-36.31M-34.57M-31.96M-25.01M-28.33M-25.48M-22.94M-23.95M-20.85M-24.83M-20.29M-23.16M-22.77M-18.43M-21.01M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-35.77M-30.5M-32.59M-36.35M-30.02M-36.31M-34.57M-31.96M-25.01M-28.33M-25.48M-22.94M-23.95M-20.85M-24.83M-20.29M-23.16M-22.77M-18.43M-21.01M
Net Margin %--------------------
Net Income Growth %-19.14%15.98%5.73%-13.74%-20.03%-28.16%-35.67%-39.31%-4.45%-35.89%-2.61%-13.1%-3.39%8.45%-34.75%3.44%-40.28%19.42%27.88%-90.58%
Net Income (Continuing)-35.77M-30.5M-32.59M-36.35M-30.02M-36.31M-34.57M-31.96M-25.01M-28.33M-25.48M-22.94M-23.95M-20.85M-24.83M-20.29M-23.16M-22.77M-18.43M-21.01M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.34-0.30-0.33-0.47-0.42-0.51-0.49-0.45-0.37-0.49-0.44-0.50-0.53-0.52-0.63-0.51-0.59-0.58-0.47-0.57
EPS Growth %19.05%41.18%32.65%-4.44%-13.51%-4.08%-11.36%10%30.19%5.77%30.16%1.96%10.17%10.34%-34.04%10.53%-31.11%30.95%44.05%-11.76%
EPS (Basic)-0.34-0.30-0.33-0.47-0.42-0.51-0.49-0.45-0.37-0.49-0.44-0.50-0.53-0.52-0.63-0.51-0.59-0.58-0.47-0.57
Diluted Shares Outstanding105.47M87.79M98.95M78.13M71.04M70.65M70.54M70.35M67.35M57.46M57.4M45.65M45.09M40.13M39.58M39.48M39.43M39.39M39.01M36.7M
Basic Shares Outstanding105.47M87.79M98.95M78.13M71.04M70.65M70.54M70.35M67.35M57.46M57.4M45.65M45.09M40.13M39.58M39.48M39.43M39.19M39.01M36.7M
Dividend Payout Ratio--------------------